145 related articles for article (PubMed ID: 35727735)
1. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells.
Chen X; Niu W; Fan X; Yang H; Zhao C; Fan J; Yao X; Fang Z
Neuro Oncol; 2023 Jan; 25(1):82-96. PubMed ID: 35727735
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells.
Chao Q; Li X; Huang Y
J Cancer Res Ther; 2023 Dec; 19(6):1636-1645. PubMed ID: 38156932
[TBL] [Abstract][Full Text] [Related]
3. Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.
Fan X; Yang H; Zhao C; Hu L; Wang D; Wang R; Fang Z; Chen X
Stem Cell Res Ther; 2021 Feb; 12(1):107. PubMed ID: 33541421
[TBL] [Abstract][Full Text] [Related]
4. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
5. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression.
Xia H; Liu Y; Wang Z; Zhang W; Qi M; Qi B; Jiang X
Neurotherapeutics; 2020 Apr; 17(2):754-764. PubMed ID: 31691127
[TBL] [Abstract][Full Text] [Related]
8. USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion.
Zhou Y; Meng X; He W; Li X; Zhao R; Dong C; Yuan D; Yang J; Zhang R; Shi G; Huang Y; Liu J; Liu J; Liu S; Fu P; Sun M
Neuro Oncol; 2022 Sep; 24(9):1482-1493. PubMed ID: 35287174
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
[TBL] [Abstract][Full Text] [Related]
11. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
[TBL] [Abstract][Full Text] [Related]
12. Propofol enhances stem-like properties of glioma via GABA
Fan X; Gong M; Yu H; Yang H; Wang S; Wang R
Stem Cell Res Ther; 2022 Aug; 13(1):398. PubMed ID: 35927718
[TBL] [Abstract][Full Text] [Related]
13. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
[TBL] [Abstract][Full Text] [Related]
14. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.
Auffinger B; Tobias AL; Han Y; Lee G; Guo D; Dey M; Lesniak MS; Ahmed AU
Cell Death Differ; 2014 Jul; 21(7):1119-31. PubMed ID: 24608791
[TBL] [Abstract][Full Text] [Related]
15. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
[TBL] [Abstract][Full Text] [Related]
16. SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.
Hu T; Xuan R; Han E; Cai L; Xia Z
J Neurooncol; 2023 Aug; 164(1):157-170. PubMed ID: 37523046
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
[TBL] [Abstract][Full Text] [Related]
18. PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
Kim JY; Kim HJ; Jung CW; Choi BI; Lee DH; Park MJ
Oncogene; 2021 Jan; 40(3):508-521. PubMed ID: 33188296
[TBL] [Abstract][Full Text] [Related]
19. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis.
Li YP; Liu Y; Xiao LM; Chen LK; Tao EX; Zeng EM; Xu CH
Lab Invest; 2022 Jul; 102(7):691-701. PubMed ID: 35013529
[TBL] [Abstract][Full Text] [Related]
20. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
